NDC 58605-312 Maxi-tuss Gmx

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
58605-312
Proprietary Name:
Maxi-tuss Gmx
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Code:
58605
Start Marketing Date: [9]
08-01-2020
Listing Expiration Date: [11]
12-31-2021
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Flavor(s):
CHERRY (C73375)

Code Structure Chart

Product Details

What is NDC 58605-312?

The NDC code 58605-312 is assigned by the FDA to the product Maxi-tuss Gmx which is product labeled by Mcr American Pharmaceuticals, Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 58605-312-16 473 ml in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Maxi-tuss Gmx?

Do not exceed recommended dosage.Adults and children 12 years of age and over:2 teaspoonfuls (10 mL) every 4 hours, not to exceed 12 teaspoonfuls in 24 hours or as directed by a doctorChildren 6 to under 12 years of age:1 teaspoonful (5 mL) every 4 hours, not to exceed 6 teaspoonfuls in 24 hours or as directed by a doctorChildren under 6 years of age:Consult a physician

Which are Maxi-tuss Gmx UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Maxi-tuss Gmx Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Maxi-tuss Gmx?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1046631 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Solution
  • RxCUI: 1046631 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Solution
  • RxCUI: 1046631 - dextromethorphan HBr 10 MG / guaifenesin 200 MG per 5 ML Oral Solution
  • RxCUI: 1046631 - dextromethorphan HBr 20 MG / guaifenesin 400 MG per 10 ML Oral Solution

* Please review the disclaimer below.

Patient Education

Dextromethorphan


Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
[Learn More]


Guaifenesin


Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".